Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Neutral ...
The Biden administration within days is expected to select the next batch of drugs that will be subject to Medicare price ...